JP2021536506A5 - - Google Patents
Info
- Publication number
- JP2021536506A5 JP2021536506A5 JP2021536676A JP2021536676A JP2021536506A5 JP 2021536506 A5 JP2021536506 A5 JP 2021536506A5 JP 2021536676 A JP2021536676 A JP 2021536676A JP 2021536676 A JP2021536676 A JP 2021536676A JP 2021536506 A5 JP2021536506 A5 JP 2021536506A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- pain
- compound
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024020391A JP2024056875A (ja) | 2018-09-04 | 2024-02-14 | 疼痛を処置するためにフェノキシプロピルアミン化合物を使用する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862726800P | 2018-09-04 | 2018-09-04 | |
| US62/726,800 | 2018-09-04 | ||
| PCT/US2019/049492 WO2020101790A2 (en) | 2018-09-04 | 2019-09-04 | Methods of using a phenoxypropylamine compound to treat pain |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024020391A Division JP2024056875A (ja) | 2018-09-04 | 2024-02-14 | 疼痛を処置するためにフェノキシプロピルアミン化合物を使用する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021536506A JP2021536506A (ja) | 2021-12-27 |
| JP2021536506A5 true JP2021536506A5 (https=) | 2022-09-12 |
| JP7439096B2 JP7439096B2 (ja) | 2024-02-27 |
Family
ID=69641874
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536676A Active JP7439096B2 (ja) | 2018-09-04 | 2019-09-04 | 疼痛を処置するためにフェノキシプロピルアミン化合物を使用する方法 |
| JP2024020391A Pending JP2024056875A (ja) | 2018-09-04 | 2024-02-14 | 疼痛を処置するためにフェノキシプロピルアミン化合物を使用する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024020391A Pending JP2024056875A (ja) | 2018-09-04 | 2024-02-14 | 疼痛を処置するためにフェノキシプロピルアミン化合物を使用する方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11766430B2 (https=) |
| EP (1) | EP3846812A2 (https=) |
| JP (2) | JP7439096B2 (https=) |
| KR (1) | KR102886521B1 (https=) |
| CN (1) | CN112955145A (https=) |
| AU (2) | AU2019381269B2 (https=) |
| BR (1) | BR112021004030A2 (https=) |
| CA (1) | CA3110652A1 (https=) |
| CL (1) | CL2021000531A1 (https=) |
| GB (1) | GB2591937B (https=) |
| IL (1) | IL281166B2 (https=) |
| MA (1) | MA53565A (https=) |
| MX (1) | MX2021002590A (https=) |
| UA (1) | UA129837C2 (https=) |
| WO (1) | WO2020101790A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021026480A2 (pt) | 2019-06-28 | 2022-02-08 | Univ Texas | Método para reconstituir anamicina, método para preparar uma dose eficaz de uma formulação lipossômica reconstituída de anamicina e método para tratar câncer |
| JP2024520463A (ja) | 2021-05-24 | 2024-05-24 | メディコン ファーマシューティカルズ，インコーポレイテッド | 化学療法誘発性末梢神経障害に関連する疼痛の処置 |
| EP4272826A3 (en) * | 2021-05-24 | 2024-01-17 | Medicon Pharmaceuticals, Inc. | Treating pain associated with diabetic peripheral neuropathy |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4207343A (en) | 1978-06-22 | 1980-06-10 | Eli Lilly And Company | 1-Phenyl-3-(substituted phenoxy)propylamines |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| ES2244438T3 (es) * | 1999-05-24 | 2005-12-16 | Mitsubishi Pharma Corporation | Compuestos de fenoxipropilamina. |
| ES2220582T3 (es) | 1999-12-20 | 2004-12-16 | Eli Lilly And Company | Derivados de piperidina y su uso como antagonistas de receptor de serotonina. |
| ATE409475T1 (de) * | 2001-02-20 | 2008-10-15 | Dinan Timothy Gerard | Behandlung von fibromyalgie mit pindolol |
| DK1423168T3 (da) * | 2001-09-03 | 2006-05-15 | Newron Pharm Spa | Farmaceutisk præparat omfattende gabapentin eller en analog deraf og et alfa-aminoamid og dets analgetiske anvendelse |
| US20040147581A1 (en) | 2002-11-18 | 2004-07-29 | Pharmacia Corporation | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
| US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| SA08280759B1 (ar) | 2007-01-10 | 2011-05-04 | سولفاي فارماسوتيكالز بي . في | مركبات من عوامل مضادة لشبيه القنب – cb1 ومكونات هيكلية من مثبطات إعادة إمتصاص السيروتونين بأندلابين أو فلوكسامين |
| TW201039815A (en) | 2009-04-13 | 2010-11-16 | Resolvyx Pharmaceuticals Inc | Compositions and methods for the treatment of inflammation |
| RU2424799C1 (ru) | 2010-03-29 | 2011-07-27 | Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ ФЕДЕРАЛЬНОГО АГЕНТСТВА ПО ЗДРАВООХРАНЕНИЮ И СОЦИАЛЬНОМУ РАЗВИТИЮ" | Способ коррекции депрессивных расстройств производными тиетан-1,1-диоксида в эксперименте |
| DK2948143T3 (da) | 2013-01-24 | 2021-07-26 | Minerva Neurosciences Inc | Anvendelse af phenoxypropylaminforbindelser til behandling af depression |
| WO2017205399A1 (en) * | 2016-05-25 | 2017-11-30 | Minerva Neurosciences, Inc. | (2s)-1-[4-(3,4-dichlorophenyl)piperidin-l-yl]-3-[2-(5-methyl-l,3,4-oxadiazol-2-yl)benzo[b]furan-4-yloxy]propan-2-ol or its metabolite for treating anxiety disorders |
-
2019
- 2019-09-04 CN CN201980072400.4A patent/CN112955145A/zh active Pending
- 2019-09-04 WO PCT/US2019/049492 patent/WO2020101790A2/en not_active Ceased
- 2019-09-04 CA CA3110652A patent/CA3110652A1/en active Pending
- 2019-09-04 MA MA053565A patent/MA53565A/fr unknown
- 2019-09-04 UA UAA202101703A patent/UA129837C2/uk unknown
- 2019-09-04 KR KR1020217009800A patent/KR102886521B1/ko active Active
- 2019-09-04 AU AU2019381269A patent/AU2019381269B2/en active Active
- 2019-09-04 EP EP19858688.5A patent/EP3846812A2/en active Pending
- 2019-09-04 GB GB2104738.6A patent/GB2591937B/en active Active
- 2019-09-04 US US16/559,687 patent/US11766430B2/en active Active
- 2019-09-04 MX MX2021002590A patent/MX2021002590A/es unknown
- 2019-09-04 JP JP2021536676A patent/JP7439096B2/ja active Active
- 2019-09-04 BR BR112021004030-7A patent/BR112021004030A2/pt unknown
- 2019-09-04 IL IL281166A patent/IL281166B2/en unknown
-
2021
- 2021-03-03 CL CL2021000531A patent/CL2021000531A1/es unknown
-
2023
- 2023-07-13 US US18/351,682 patent/US20240016790A1/en not_active Abandoned
-
2024
- 2024-02-14 JP JP2024020391A patent/JP2024056875A/ja active Pending
-
2025
- 2025-05-30 AU AU2025204043A patent/AU2025204043A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019503365A5 (https=) | ||
| JP2021536506A5 (https=) | ||
| JP2009514874A5 (https=) | ||
| AU2013305569A1 (en) | Composition for the treatment of migraine headaches | |
| ES2813649T3 (es) | Composición farmacéutica administrable por vía oral para la prevención o el tratamiento del síndrome del ojo seco, que comprende rebamipida o un profármaco de la misma | |
| JP2023500032A5 (https=) | ||
| JP2020533296A5 (https=) | ||
| US8431601B2 (en) | Topical compositions comprising telmesteine for treating dermatological disorders | |
| JP2024531188A5 (https=) | ||
| CN101939001B (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| GB2591937A (en) | Methods of using a phenoxypropylamine compound to treat pain | |
| JP2016505050A5 (https=) | ||
| JP2023548429A5 (https=) | ||
| JP2004525143A5 (https=) | ||
| IL272834B1 (en) | Compositions of amantadine, their preparation, and methods of use | |
| RU2016137926A (ru) | Композиции грапипранта и способы их применения | |
| WO2023155837A1 (zh) | 具有镇痛和/或止痒功能的药物组合物及其用途 | |
| HRP20190211T1 (hr) | Inhibitor proteina za prijenos kolesterilestera (cetp) i farmaceutski pripravci koji sadrže spomenuti inhibitor za primjenu u liječenju ili prevenciji kardiovaskularnih bolesti | |
| KR20210015895A (ko) | 인간 및 동물에서 알레르기 질환 및 다른 질환의 치료를 위한 말론산의 비스아미드 유도체의 용도 | |
| US20090137477A1 (en) | Treatment of oropharyngeal candidiasis in cancer patients | |
| MX384760B (es) | Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco y gabapentina para el tratamiento del dolor neuropático. | |
| JP2022505184A5 (https=) | ||
| RU2021109059A (ru) | Способы применения феноксипропиламинового соединения для лечения боли | |
| MXPA06013830A (es) | Tratamiento del cancer en pacientes pediatricos. | |
| JP2022504435A5 (https=) |